Home > Annual Financials > ADVANCED ENZYME TECHNOLOGIES

ADVANCED ENZYME TECHNOLOGIES Financial Statement Analysis
[BOM: 540025|NSE : ADVENZYMES]

The Revenues of ADVANCED ENZYME TECHNOLOGIES have increased by 15.39% YoY .
The Earnings Per Share (EPS) of ADVANCED ENZYME TECHNOLOGIES has decreased by -1.68 % YoY.
COMMUNITY POLL
for ADVANCED ENZYME TECHNOLOGIES
Please provide your vote to see the results

ADVANCED ENZYME TECHNOLOGIES Last 5 Annual Financial Results
[BOM: 540025|NSE : ADVENZYMES]

ConsolidatedMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹624 Cr₹541 Cr₹529 Cr₹502 Cr₹444 Cr
Expenses ₹419 Cr₹383 Cr₹327 Cr₹269 Cr₹241 Cr
Operating Profit (Excl OI) ₹205 Cr₹158 Cr₹203 Cr₹233 Cr₹203 Cr
Other Income ₹37 Cr₹25 Cr₹6.42 Cr₹8.85 Cr₹5.88 Cr
Interest ₹4.12 Cr₹3.48 Cr₹2.96 Cr₹2.57 Cr₹4.08 Cr
Depreciation ₹35 Cr₹35 Cr₹35 Cr₹29 Cr₹26 Cr
Profit Before Tax ₹188 Cr₹140 Cr₹171 Cr₹210 Cr₹179 Cr
Profit After Tax ₹137 Cr₹104 Cr₹124 Cr₹151 Cr₹133 Cr
Consolidated Net Profit ₹133 Cr₹106 Cr₹120 Cr₹146 Cr₹129 Cr
Earnings Per Share (Rs)₹11.72₹11.92₹9.45₹10.70₹13.06
PAT Margin (%)21.0321.9219.1823.3430.41
ROE(%)9.7910.728.9412.0416.77
ROCE(%)13.7614.7812.2616.6622.93
Total Debt/Equity(x)0.020.020.010.010.02

Key Financials

Market Cap : ₹ 4,156.9 Cr
Revenue (TTM) : ₹ 745.8 Cr
Net Profit(TTM) : ₹ 173.6 Cr
EPS (TTM) : ₹ 15.5
P/E (TTM) : 23.9

Industry Peers & Returns1W1M1Y
ADVANCED ENZYME TECHNOLOGIES -4.3% 12.2% 30.3%
SUN PHARMACEUTICAL INDUSTRIES -2.4% 6.4% 7%
DIVIS LABORATORIES -0.9% 5% 3.3%
TORRENT PHARMACEUTICALS 1.6% 7.6% 38.5%
CIPLA 1.2% 7.7% -3.4%
DR REDDYS LABORATORIES 0.1% -1.2% 8.7%
MANKIND PHARMA -3.7% 6.8% -0.8%
LUPIN -0.4% -2% 15%
ZYDUS LIFESCIENCES 4.8% 16.5% 19.4%


ADVANCED ENZYME TECHNOLOGIES Revenues
[BOM: 540025|NSE : ADVENZYMES]

Y-o-Y

15.39 %

5 Yr CAGR

8.88 %

Years Revenues % Change
Mar2025 ₹624 Cr
15.39
Mar2024 ₹541 Cr
2.13
Mar2023 ₹529 Cr
5.49
Mar2022 ₹502 Cr
13.03
Mar2021 ₹444 Cr -


ADVANCED ENZYME TECHNOLOGIES Operating Profit
[BOM: 540025|NSE : ADVENZYMES]

Y-o-Y

30.38 %

5 Yr CAGR

0.27 %

Years Operating Profit % Change
Mar2025 ₹205 Cr
30.38
Mar2024 ₹158 Cr
-22.25
Mar2023 ₹203 Cr
-12.90
Mar2022 ₹233 Cr
14.49
Mar2021 ₹203 Cr -

Operating Margins
Y-o-Y

12.98 %

5 Yr CAGR

-7.91 %

Years Operating Margin% % Change
Mar2025 32.91%
12.98
Mar2024 29.13%
-23.88
Mar2023 38.27%
-17.41
Mar2022 46.34%
1.29
Mar2021 45.75% -

ADVANCED ENZYME TECHNOLOGIES Profit After Tax
[BOM: 540025|NSE : ADVENZYMES]

Y-o-Y

26.19 %

5 Yr CAGR

0.77 %

Years Profit After Tax % Change
Mar2025 ₹133 Cr
26.19
Mar2024 ₹106 Cr
-11.66
Mar2023 ₹120 Cr
-18.06
Mar2022 ₹146 Cr
12.87
Mar2021 ₹129 Cr -

PAT Margins
Y-o-Y

-4.06 %

5 Yr CAGR

-8.81 %

Years PAT Margin(%) % Change
Mar2025 21.03 %
-4.06
Mar2024 21.92 %
14.29
Mar2023 19.18 %
-17.82
Mar2022 23.34 %
-23.25
Mar2021 30.41 % -

ADVANCED ENZYME TECHNOLOGIES Earnings Per Share (EPS)
[BOM: 540025|NSE : ADVENZYMES]

Y-o-Y

-1.68 %

5 Yr CAGR

-2.67 %

Years EPS % Change
Mar2025 ₹12
-1.68
Mar2024 ₹12
26.14
Mar2023 ₹9.45
-11.68
Mar2022 ₹11
-18.07
Mar2021 ₹13 -

ADVANCED ENZYME TECHNOLOGIES Return on Capital Employed (ROCE)
[BOM: 540025|NSE : ADVENZYMES]

Y-o-Y

-6.90 %

5 Yr CAGR

-11.99 %

Years ROCE % Change
Mar2025 13.76%
-6.90
Mar2024 14.78%
20.55
Mar2023 12.26%
-26.41
Mar2022 16.66%
-27.34
Mar2021 22.93% -

ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex

Current Share Price : ₹371.2
Current MarketCap: ₹ 4,156.9 Cr
Updated EOD on :May 27,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
ADVANCED ENZYME TECHNOLOGIES

-4.3%

12.2%

30.3%

SENSEX

0.7%

-1%

-7%

ADVANCED ENZYME TECHNOLOGIES related INDICES

BSE Indices1W1M1Y
BSE 1000 1.8% 1.8% 0.7%
BSE HEALTHCARE -0.4% 8.8% 11.5%
NSE Indices1W1M1Y
NIFTY MICROCAP 250 3.5% 5.6% 3.3%
NIFTY SMALLCAP 500 2.8% NA NA
NIFTY TOTAL MARKET 1.8% 1.9% 1.1%

You may also like the below Video Courses


FAQ about ADVANCED ENZYME TECHNOLOGIES Financials


How the annual revenues of ADVANCED ENZYME TECHNOLOGIES have changed ?

The Revenues of ADVANCED ENZYME TECHNOLOGIES have increased by 15.39% YoY .

How the Earnings per Share (EPS) of ADVANCED ENZYME TECHNOLOGIES have changed?

The Earnings Per Share (EPS) of ADVANCED ENZYME TECHNOLOGIES has decreased by -1.68 % YoY .